Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Ishida, T.
Kanazawa, K.
Oizumi, H.
Yokouchi, H.
Yamazaki, K.
Akie, K.
Sukoh, N.
Harada, M.
Munakata, M.
Isobe, H.
机构：
[1] Fukushima Med Univ, Fukushima, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan
[4] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[5] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18121
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Hidehito Horinouchi
    Noboru Yamamoto
    Hiroshi Nokihara
    Takeshi Horai
    Makoto Nishio
    Fumiyoshi Ohyanagi
    Atsushi Horiike
    Kazuhiko Nakagawa
    Masaaki Terashima
    Takafumi Okabe
    Hiroyasu Kaneda
    Mark D. McKee
    Dawn M. Carlson
    Hao Xiong
    Tomohide Tamura
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 37 - 43
  • [42] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Horai, Takeshi
    Nishio, Makoto
    Ohyanagi, Fumiyoshi
    Horiike, Atsushi
    Nakagawa, Kazuhiko
    Terashima, Masaaki
    Okabe, Takafumi
    Kaneda, Hiroyasu
    McKee, Mark D.
    Carlson, Dawn M.
    Xiong, Hao
    Tamura, Tomohide
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 37 - 43
  • [43] Sequential carboplatin-gemcitabine (CG) and docetaxel (D) in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): A phase II trial.
    Murad, AM
    Guimaraes, RC
    Scalabrini-Neto, AO
    Papa, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 708S - 708S
  • [44] Phase II study of erlotinib plus gemcitabine in first-line treatment of poor prognosis, advanced non-small cell lung cancer patients
    Grigorescu, A. C.
    Bala, C.
    [J]. JOURNAL OF BUON, 2013, 18 (01): : 188 - 194
  • [45] A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer
    Moore, T
    Patel, T
    Segal, M
    Thompson, J
    Zangmeister, J
    Larrimer, N
    Merriman, N
    Chidiac, T
    [J]. LUNG CANCER, 2005, 49 : S259 - S259
  • [46] Docetaxel and Oxaliplatin as First-Line Therapy for Advanced Non-Small Cell Lung Cancer: A Phase II Trial
    Radhakrishnan, A.
    Bitran, J. D.
    Milton, D. T.
    Tolzien, K.
    Hallmeyer, S.
    Nabhan, C.
    [J]. JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 439 - 444
  • [47] First line treatment of non-small cell lung carcinoma (NSCLC) with docetaxel and vinorelbine: A phase II study
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Vamvakas, L
    Heras, P
    Metaxaris, G
    Maltezakis, G
    Chalkiadakis, G
    Vlachonikolis, J
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    [J]. 2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 673 - 679
  • [48] Randomized phase II study of vandetanib (VAN) alone or in combination with carboplatin and paclitaxel (CP) as first-line treatment for advanced non-small cell lung cancer (NSCLC)
    Heymach, J.
    Paz-Ares, L.
    De Braud, F.
    Sebastian, M.
    Stewart, D. J.
    Eberhardt, W.
    Herbst, S.
    Krebs, A.
    Langmuir, P.
    Johnson, B. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] ACTIVITY AND TOLERABILITY OF CARBOPLATIN AND GEMCITABINE IN FIRST-LINE TREATMENT OF ELDERLY THAI PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Charoentum, Chaiyut
    Theerakittikul, Theerakorn
    Saeteng, Somcharone
    Euathrongchit, Juntima
    Lertprasertsuke, Nirush
    Ariyawutyakorn, Witthawat
    Chewaskulyong, Busyamas
    Thongprasert, Sumitra
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1313 - S1313
  • [50] Docetaxel (Taxotere®) and Carboplatin in the treatment of advanced non-small lung cancer (NSCLC)
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
12345